MTFR2 and neoplasm: In this study, we found that MTFR2 expression was significantly overexpressed in LUAD and a high expression of MTFR2 was associated with advanced TNM stages and poor survival in LUAD patients, which suggested that MTFR2 may be a tumor promoter in LUAD.